| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
12-01-2010, 03:48 PM
|
#1 | |||
|
||||
|
Senior Member
|
Allon gets MJFF grant for parkinson's disease drug Davunetide
PBR Staff Writer Published 01 December 2010 Allon Therapeutics has received $625,000 in Michael J Fox Foundation (MJFF) grant to conduct pre-clinical research that will help determine the potential of the company's lead neuroprotective drug, Davunetide, as a treatment for parkinson's disease (PD). The newly funded research project will focus on the impact ...on ... alpha-synuclein. http://contractresearch.pharmaceutic...unetide-011210
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| MJFF: Third Annual Parkinson's Disease Therapeutics Conference / Sept 2009 | Parkinson's Disease | |||
| Merck Serono to fund $2mn MJFF drive against Parkinson's Disease | Parkinson's Disease | |||
| Byetta (diabetes drug) Cures Parkinson's Disease in Rats | Parkinson's Disease | |||
| Drug slows and may halt Parkinson's disease | Parkinson's Disease | |||
Allon gets MJFF grant for parkinson's disease drug Davunetide
Linear Mode
